Albertsons Lawsuit Alleges ‘Hypoallergenic’ Signature Care Sensitive Skin Body Wash Contains Known Allergens
Flores v. Albertsons Companies, Inc.
Filed: August 29, 2025 ◆§ 2:25-cv-02476
A class action accuses Albertsons of misrepresenting its “hypoallergenic” Signature Care Sensitive Skin Body Wash, given that the product contains common allergens.
California
A proposed class action lawsuit accuses Albertsons Companies of misrepresenting its “hypoallergenic” Signature Care Sensitive Skin Body Wash, given that the product contains several common allergens.
Get the latest open class action lawsuits sent to your inbox. Sign up for ClassAction.org’s free weekly newsletter.
According to the 34-page lawsuit, Albertsons has misled consumers into believing the item at issue is “hypoallergenic,” formulated for sensitive skin and comparable to Dove-brand Sensitive Skin Body Wash. The defendant makes these claims in a bid to capitalize on increasing demand for “cleaner” beauty products that are free from harsh chemicals, fragrances or additives that may cause a reaction, the complaint contends.
Contrary to the representations, the Albertsons Signature Care body wash contains some of the most predominant contact allergens found in beauty products, including methylchloroisothiazolinone (MCI), methylisothiazolinone (MI) and cocamidopropyl betaine (CAPB), the suit asserts. In particular, MCI and MI—used as preservatives in cosmetics and other personal care items—are a common cause of allergic contact dermatitis, which appears as an itchy red rash on the skin, the case says.
The complaint reports that as of 2018, nearly 11 percent of the North American population had become “sensitized,” or had developed an allergic response, to MCI and MI.
The front-label claim that Albertsons’ body wash is comparable to Dove Sensitive Skin Body Wash is deceptive because Dove’s product does not contain MCI or MI, the filing contends.
Per the suit, the body wash at issue also contains CAPB, which was named “Allergen of the Year” in 2004 by the American Contact Dermatitis Society due to increasing rates of sensitization.
According to the Albertsons body wash lawsuit, consumers expect an item labeled “hypoallergenic” to be specially formulated to minimize the risk of allergic reactions by being free from ingredients known to cause them.
The case alleges that consumers would not have paid a premium price for the supposedly “hypoallergenic” body wash, or bought it at all, had they known it contained three well-known allergens.
The lawsuit looks to represent all individuals who, within the applicable statute of limitations period, purchased Albertsons’ “hypoallergenic” Signature Care Sensitive Skin Body Wash for personal, household or family use in Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, the District of Columbia, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Maine, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia or Wyoming.
Learn all about the legal process: What is a class action lawsuit?
Video Game Addiction Lawsuits
If your child suffers from video game addiction — including Fortnite addiction or Roblox addiction — you may be able to take legal action. Gamers 18 to 22 may also qualify.
Learn more:Video Game Addiction Lawsuit
Depo-Provera Lawsuits
Anyone who received Depo-Provera or Depo-Provera SubQ injections and has been diagnosed with meningioma, a type of brain tumor, may be able to take legal action.
Read more: Depo-Provera Lawsuit
How Do I Join a Class Action Lawsuit?
Did you know there's usually nothing you need to do to join, sign up for, or add your name to new class action lawsuits when they're initially filed?
Read more here: How Do I Join a Class Action Lawsuit?
Stay Current
Sign Up For
Our Newsletter
New cases and investigations, settlement deadlines, and news straight to your inbox.
Before commenting, please review our comment policy.